MCL1 and Miyoshi myopathy: found that the bone marrow stromal cells in tumor microenvironment can decrease the miR-193b-3p expression in MM cells and mediate the upregulation of MCL-1, while a concomitant increase in miR-21-5p expression regulates a decrease in BCL-2 levels.